Olink, part of Thermo Fisher Scientific Industry Symposium: Advancing Cancer Research Beyond the Genome with Plasma Proteomics

Proteomics is reshaping cancer research by providing functional insights that extend beyond the genome. This session highlights how high-throughput plasma protein profiling supports biomarker discovery, patient stratification, and a deeper understanding of cancer biology. Our speakers will present applications spanning early detection, immuno-oncology, and translational research, showcasing the expanding role of proteomics across the cancer research continuum. Together, these examples underline the potential of scalable proteomic approaches to generate more precise, biologically meaningful, and clinically relevant insights in oncology.